Back
Sunnova Energy International 10K Form
Sell
15
NOVA
Sunnova Energy International
Last Price:
$0.41
Seasonality Move:
38.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-03-06 | 10K | NOVA/Sunnova Energy International Annual |
| 2020-02-25 | 10K | NOVA/Sunnova Energy International Annual |
| 2019-10-31 | 10Q | NOVA/Sunnova Energy International Quarterly |
| 2019-08-19 | 10Q | NOVA/Sunnova Energy International Quarterly |
Receive NOVA News And Ratings
See the #1 stock for the next 7 days that we like better than NOVA
NOVA Financial Statistics
Sales & Book Value
| Annual Sales: | $839.9M |
|---|---|
| Cash Flow: | $-384.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $14.65 |
| Price / Book: | 0.03 |
Profitability
| EPS (TTM): | -2.96000 |
|---|---|
| Net Income (TTM): | $-367.9M |
| Gross Margin: | $377M |
| Return on Equity: | -14.72% |
| Return on Assets: | -2.97% |
Sunnova Energy International Earnings Forecast
Key Sunnova Energy International Financial Ratios
-
The Gross Profit Margin over the past 8 years for NOVA is 44.88%.
-
The Selling, General & Administrative Expenses for NOVA have been equal to 45.62% of Gross Profit Margin.
-
The Net Earning history of NOVA is -43.80% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Sunnova Energy International Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Independent Power & Renewable Electricity Producer |
| Sector: | Utilities |
| Current Symbol: | NOVA |
| Website: | sunnova.com |
Debt
| Debt-to-Equity Ratio: | 4.62 |
|---|---|
| Current Ratio: | 0.78 |
| Quick Ratio: | 0.59 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NOVA Technical Analysis vs Fundamental Analysis
Sell
15
Sunnova Energy International (NOVA)
is a Sell
Is Sunnova Energy International a Buy or a Sell?
-
Sunnova Energy International stock is rated a SellThe current Sunnova Energy International [NOVA] share price is $0.41. The Score for NOVA is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.